Data / Drug companies / Vitamin K
Vitamin K drugs: 3 drugs from 33 companies in the FDA NDC directory
Vitamin K is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 44 products in this class from 33 companies, covering 3 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 28, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 33Companies
- 44Products
- 3Drugs by generic name
Drugs in the Vitamin K class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Phytonadione | 37 | 31 |
| Vitamin k1 - phytonadione | 1 | 1 |
| Vitamin k1, phytonadione | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Cipla USA Inc. | 4 | injection, emulsion; tablet | Generic drugs (ANDA) | January 15, 2025 |
| Fresenius Kabi USA, LLC | 4 | emulsion; injection, emulsion | Unapproved drugs for a shortage | May 10, 2025 |
| HF Acquisition Co LLC, DBA HealthFirst | 3 | injection, emulsion | Generic drugs (ANDA) | November 1, 2021 |
| Dr. Reddy's Laboratories Inc. | 2 | injection, emulsion | Generic drugs (ANDA) | October 5, 2026 |
| Henry Schein, Inc. | 2 | injection, emulsion | Generic drugs (ANDA) | January 13, 2022 |
| Hospira, Inc. | 2 | injection, emulsion | Generic drugs (ANDA) | July 27, 2005 |
| Agnitio Inc. | 1 | tablet | Generic drugs (ANDA) | February 11, 2022 |
| Alembic Pharmaceuticals Inc. | 1 | injection, emulsion | Generic drugs (ANDA) | September 8, 2025 |
| Alembic Pharmaceuticals Limited | 1 | injection, emulsion | Generic drugs (ANDA) | September 8, 2025 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | June 21, 2018 |
| Amneal Pharmaceuticals LLC | 1 | injection, emulsion | Generic drugs (ANDA) | November 4, 2025 |
| Amneal Pharmaceuticals NY LLC | 1 | tablet | Generic drugs (ANDA) | May 15, 2018 |
| Amneal Pharmaceuticals Private Limited | 1 | injection, emulsion | Generic drugs (ANDA) | June 1, 2026 |
| Baxter Healthcare Corporation | 1 | injection, emulsion | Generic drugs (ANDA) | February 26, 2026 |
| Bottled Science, Inc. | 1 | spray | Unapproved homeopathic products | July 24, 2019 |
| Caplin Steriles Limited | 1 | injection, emulsion | Generic drugs (ANDA) | April 26, 2025 |
| Coupler LLC | 1 | tablet | Generic drugs (ANDA) | September 8, 2025 |
| Exelan Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | December 1, 2023 |
| Gland Pharma Limited | 1 | injection, emulsion | Generic drugs (ANDA) | December 10, 2024 |
| Glenmark Pharmaceuticals Inc., USA | 1 | injection, emulsion | Generic drugs (ANDA) | December 10, 2024 |
| International Medication Systems, Limited | 1 | injection, emulsion | Generic drugs (ANDA) | April 18, 2003 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | May 15, 2018 |
| NorthStar Rx LLC | 1 | tablet | Generic drugs (ANDA) | March 22, 2022 |
| Orbicular Pharmaceutical Technologies Private Limited | 1 | injection, emulsion | Generic drugs (ANDA) | March 24, 2026 |
| Padagis US LLC | 1 | tablet | Generic drugs (ANDA) | October 28, 2026 |
| PureTek Corporation | 1 | tablet | Other unapproved drugs | January 26, 2024 |
| Safecor Health, LLC | 1 | tablet | Generic drugs (ANDA) | September 2, 2026 |
| Sagent Pharmaceuticals | 1 | injection, emulsion | Generic drugs (ANDA) | February 1, 2026 |
| ScieGen Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | July 28, 2023 |
| Sun Pharmaceutical Industries, Inc. | 1 | injection, emulsion | Generic drugs (ANDA) | June 10, 2026 |
| Xiromed, LLC | 1 | injection, emulsion | Generic drugs (ANDA) | August 28, 2025 |
| Zydus Lifesciences Limited | 1 | tablet | Generic drugs (ANDA) | February 22, 2019 |
| Zydus Pharmaceuticals USA Inc. | 1 | tablet | Generic drugs (ANDA) | February 22, 2019 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, emulsion | 26 | 59.1% |
| Tablet | 14 | 31.8% |
| Emulsion | 3 | 6.8% |
| Spray | 1 | 2.3% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.